Diabetologia

, Volume 31, Issue 6, pp 385–389 | Cite as

Metformin enhances certain insulin actions in cultured rat hepatoma cells

  • F. Purrello
  • D. Gullo
  • M. Buscema
  • V. Pezzino
  • R. Vigner
  • I. D. Goldfine
Originals

Summary

The effect of the oral antidiabetic agent metformin on insulin regulation of glycogen metabolism, tyrosine-aminotransferase activity, and [1-14C]aminoisobutyric acid uptake was studied in H4IIE cultured rat hepatoma cells. Metformin enhanced both basal (from 0.213±0.016 to 0.262±0.024 nmol/mg protein,p<0.01) and insulin stimulated [3H] glucose incorporation into glycogen in a time-dependent and dose-dependent manner. A small effect of metformin was seen at 1 μmol/l, and its greatest effects were obtained at 10 μmol/l. At the same concentrations, metformin did not influence basal tyrosine-aminotransferase activity but it potentiated insulin stimulated tyrosine-aminotransferase activity (+ 29.2±1.4%,p<0.01) and prevented the loss of tyrosine-aminotransferase responsiveness to insulin in H4IIE cells desensitised by a previous exposure to insulin. In contrast, metformin had no effect on basal or insulin-stimulated [1-14C]aminoisobutyric acid uptake. Over the concentrations of metformin that enhanced insulin action in H4IIE cells, the drug had no significant effect on insulin binding to its receptor. These studies suggest, therefore, that metformin may influence cellular metabolism by potentiating certain insulin actions through mechanisms that may be beyond insulin receptor binding.

Key words

Metformin insulin action hepatoma cells 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hermann LS (1979) Metformin: a review of its pharmacological properties and therapeutic use. Diabete Metab 5: 233–245PubMedGoogle Scholar
  2. 2.
    Lucis OJ (1983) Pharmacologie update. The status of metformin in Canada. Can Med Assoc J 128: 24–26PubMedGoogle Scholar
  3. 3.
    Vigneri R, Goldfine ID (1987) Role of metformin in treatment of diabetes mellitus. Diabetes Care 10: 118–122PubMedGoogle Scholar
  4. 4.
    Pezzino V, Trischitta V, Purrello F, Vigneri R (1982) Effect of metformin on insulin binding to receptors in cultured human lymphocytes and breast cancer cells. Diabetologia 23: 131–135CrossRefPubMedGoogle Scholar
  5. 5.
    Holle A, Mangels W, Dreyer M, Kuhnau J, Rudiger HW (1981) Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes. N Engl J Med 305: 563–566PubMedGoogle Scholar
  6. 6.
    Trischitta V, Gullo D, Pezzino V, Vigneri R (1983) Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients. J Clin Endocrinol Metab 57: 713–718PubMedGoogle Scholar
  7. 7.
    Lord JM, White SI, Bailey CJ, Atkins TW, Fletcher RF, Taylor KG (1983) Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes. Br Med J 286: 830–831Google Scholar
  8. 8.
    Prager R, Schernthaner G (1983) Insulin receptor binding to monocytes, insulin secretion, and glucose tolerance following metformin treatment. Results of a double-blind cross-over study in type II diabetics. Diabetes 32: 1083–1086PubMedGoogle Scholar
  9. 9.
    Lord JM, Atkins TW, Bailey CJ (1983) Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice. Diabetologia 25: 108–113CrossRefPubMedGoogle Scholar
  10. 10.
    Iwamoto Y, Wong KY, Goldfine ID (1981) Insulin action in cultured HTC and H35 rat hepatoma cells: receptor binding and hormone sensitivity. Endocrinology 108: 44–51PubMedGoogle Scholar
  11. 11.
    Diamondstone TI (1966) Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenz-aldehyde. Anal Biochem. 16: 395–401CrossRefGoogle Scholar
  12. 12.
    Hofmann C, Marsh JW, Miller B, Steiner DF (1980) Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness. Diabetes 29: 865–874PubMedGoogle Scholar
  13. 13.
    Crettaz M, Kahn CR (1984) Insulin Receptor regulation and densensitization in rat hepatoma cells. Diabetes 33: 477–485PubMedGoogle Scholar
  14. 14.
    Sirtori CR, Franceschini G, Galli-Klenle M, Cighetti G, Galli G, Bondioli A, Conti F (1978) Disposition of metformin (N,N-dime- thylbiguanide) in man. Clin Pharmacol Ther 24: 683–693PubMedGoogle Scholar
  15. 15.
    Vigneri R, Pezzino V, Wong KY, Goldfine ID (1982) Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding to its receptors in target cells. J Clin Endocrinol Metab 54: 95–100PubMedGoogle Scholar
  16. 16.
    Cigolini M, Bosello O, Zancanaro C, Orlandi BG, Fezzi O, Smith U (1984) Influence of metformin on metabolic effects of insulin in human adipose tissue “in vitro”. Diabet Metab 10: 311–315Google Scholar
  17. 17.
    Lockwood DH, Maloff BL, Nowak SM, McCaleb ML (1983) Extrapancreatic effects of sulfonylureas. Potentiation of insulin action through post-binding mechanisms. Am J Med 74: 102–108CrossRefPubMedGoogle Scholar
  18. 18.
    Salhanick AI, Konowitz P, Amatruda JM (1983) Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats. Diabetes 32: 206–212PubMedGoogle Scholar
  19. 19.
    Fleig WE, Noether-Fleig G, Fussgaenger R, Ditschuneit H (1984) Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Evidence for a postreceptor mechanism of action. Diabetes 33: 285–290PubMedGoogle Scholar
  20. 20.
    Jacobs DB, Hayes GR, Truglia JA, Lockwood DH (1987) Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes. Diabetologia 29: 798–801Google Scholar
  21. 21.
    Purrello F, Gullo D, Brunetti A, Buscema M, Italia S, Goldfine ID, Vigneri R (1987) Direct effects of biguanides on glucose utilization in vitro. Metabolism 36: 774–776CrossRefPubMedGoogle Scholar
  22. 22.
    Fantus GI, Brosseau R (1986) Mechanism of action of metformin: insulin receptor and postreceptor in vitro and in vivo. J Clin Endocrinol Metab 63: 898–905PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • F. Purrello
    • 1
  • D. Gullo
    • 1
  • M. Buscema
    • 1
  • V. Pezzino
    • 1
  • R. Vigner
    • 1
  • I. D. Goldfine
    • 2
    • 3
  1. 1.Cattedra di Endocrinologia e Patologia CostituzionaleUniversity of CataniaCataniaItaly
  2. 2.Cell Biology LaboratoryMount Zion HospitalUSA
  3. 3.Departments of Medicine and PhysiologyUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations